OPTI shares have soared in July. Is it too late to get in, or is the company just getting started?
OPTI shares have soared in July. Is it too late to get in, or is the company just getting started?
Launch of GoFigure products on Tmall China
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular diseaseanddiabetes, provides the following unaudited trading update ahead of the Group’s half year results for
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
Amazon announced Thursday that it has acquired One Medical, a primary care provider for healthcare.
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, notes the announcement (14 June 2022) by ProBiotix Health plc
SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space.
SEED Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space.
Cambridge, UK, 30 July 2021 – Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases.
SEED Innovations Limited, the AIM quoted company focusing on making investments in fast growing and industry leading businesses with a focus on investing within the medical cannabis, health and wellness
Completed Covid-19 Research Project Delivers Encouraging Results